📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetically proxied therapeutic prolyl-hydroxylase inhibition and cardiovascular risk. (2023)

First Author: Harlow CE

Attributed to: Using genetics to test the disease consequences of higher adiposity uncoupled from its adverse metabolic effects funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddac215

PubMed Identifier: 36048866

Publication URI: http://europepmc.org/abstract/MED/36048866

Type: Journal Article/Review

Volume: 32

Parent Publication: Human molecular genetics

Issue: 3

ISSN: 0964-6906